Why Carlsmed, Inc.’s (CARL) Stock Is Up 5.30%
As of Tuesday, November 17, Carlsmed, Inc.’s CARL share price has surged by 5.30%, which has investors questioning if this is right time to sell.Jenna Brashear
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
Jenna Brashear
Rosalio Madrigal
Michael Rose
Jenna Brashear
Rosalio Madrigal
| Share Statistics | CARL | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $471.9 | $356.4 | 38% |
|
| Shares Out (Mil) | 27.3 | 41.2 | 35% |
|
| Institutional Ownership | 69.3% | 83.1% | 42% |
|
| Float (Mil) | 15.7 | 36.7 | 25% |
|
| Beta | na | 0.89 | na |
|
| Avg Daily Volume (000s) | 235 | 318 | 47% |
|
| Price Change (52-week) |
40.6% | 55.9% | 83% |
|
| Growth | CARL | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | na | 11.8% | na |
|
| Net Income (5yr) | na | (5.8%) | na |
|
| EPS (5yr) | na | 10.6% | na |
|
| Dividends (5yr) | na | 0.0% | 0% |
|
| Cash Flow (5yr) | na | (15.6%) | na |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 1 | 1 | 1 | |
| Current EPS | ($0.410) | ($1.510) | ($1.560) | |
| Month Ago EPS | ($0.340) | ($1.410) | ($1.380) | |
| # Rev Up | 0 | 0 | 0 | |
| # Rev Down | 1 | 1 | 1 | |
| Three Months Ago EPS | ($0.340) | ($1.410) | ($1.380) | |
| Year/Year Chg | (8.5%) | (28.9%) | (45.9%) | |
| Financials | CARL | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $72 | $123 | 23% |
|
| Net Income (TTM) (Mil) | ($40) | ($9) | 18% |
|
| EPS (TTM) | ($1.483) | ($0.300) | 17% |
|
| Operating Cash Flow (TTM) (Mil) | ($34) | ($1) | 12% |
|
| Net Cash Flow (TTM) (Mil) | ($79) | $2 | 17% |
|
| Long-Term Debt (Q1) (Mil) | $21 | $21 | 33% |
|
| Enterprise Value (Q1) (Mil) | $411 | $381 | 33% |
|
| Valuation | CARL | Industry Median |
Percentile (All Stocks) |
|
| P/B | 6.24 | 2.46 | 86% |
|
| P/E | na | 25.5 | na |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 1.3 | na |
|
| Ratios | CARL | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 77.0% | 59.1% | 87% |
|
| Net Margin | (55.8%) | (4.6%) | 11% |
|
| ROA | (32.0%) | (9.9%) | 16% |
|
| ROE | (43.9%) | (8.5%) | 16% |
|
| Liabilities to Assets | 34.4% | 45.6% | 25% |
|
| F-Score | 2 | 4 | 7% |
|
Carlsmed, Inc. did not pass any screens on 11/19/2026.
Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.
Ⓒ 2026 American Association of Individual Investors